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Sexual dysfunction in female hemodialysis patients: A
multicenter study.
Background. Sexual function is one aspect of physical func-
tioning. Sexual dysfunction, no matter the etiology, could cause
distress. In female hemodialysis patients, sexual problems have
often been neglected in clinical performance and research.
Methods. We conducted this study by use of self-reported
questionnaires. A total of 578 female hemodialysis patients in
northern Taiwan were included in this study. Demographic data,
comorbid diseases, medications in use, biochemical, and hema-
tologic parameters were analyzed. All patients were asked to
complete by themselves three questionnaires: (1) the Index of
Female Sexual Function (IFSF) to assess sexual function; (2)
the Beck Depression Inventory (BDI) (Chinese version) to rate
the severity of depressive symptoms; and (3) the 36-item Short
Form Health Survey Questionnaire (SF-36, Taiwan Standard
Version 1.0) to survey their quality of life.
Results. A total of 138 female patients were enrolled into
further analysis. The mean age was 48.7 ± 11.2 years old. The
mean IFSF score was 24.5 ± 9.3. Age, BDI score, and serum
triglyceride levels were the independent factors of dysfunction
in each sexual functional dimension. Patients with higher IFSF
scores had significantly higher scores in physical functioning and
mental health (P = 0.007 and 0.018, respectively). Patients with
higher intercourse satisfaction had significantly higher general
health scores (P = 0.001).
Conclusion. Sexual dysfunction is frequent in the female
hemodialysis population. It is strongly associated with increas-
ing age, dyslipidemia, and depression. The subjects with sexual
dysfunction had poorer quality of life. The diagnosis and treat-
ment of sexual dysfunction should be included in the clinical
assessment.
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With advances in medical care, the survival of
hemodialysis patients has been prolonged [1]. The aim of
medical care has evolved beyond the support of life only.
Enhancing patients’ physical functioning and quality of
life has become more and more important. Sexual func-
tion is one aspect of physical functioning. Sexual dysfunc-
tion, usually multifactorial in etiology, is highly prevalent
in hemodialysis patients [2]. Sexual dysfunction can cause
marked distress and interpersonal difficulties [3]. Diag-
nosis and treatment of sexual dysfunction should be in-
cluded in the global health assessment of hemodialysis
patients.
Previous research of sexual dysfunction in hemodial-
ysis patients is almost entirely focused on erectile dys-
function of men. Research on the sexual problems
encountered by women is primarily concerning hormonal
imbalances, ovulation, or pregnancy [2]. Studies address-
ing decreased libido and sexual function are lacking [4].
A major obstacle in the design of such clinical studies
is the need for reliable measurement techniques. Of the
measures currently available, self-reported event logs or
questionnaires are best suited for research or clinical as-
sessment of female sexual function [5]. By use of self-
reported questionnaires, we conducted a study to identify
the prevalence and possible factors of sexual dysfunction
in female hemodialysis patients.
METHODS
Subjects
A total of 578 female patients with end-stage renal dis-
ease (ESRD) receiving hemodialysis at 14 hospitals or
dialysis centers in northern Taiwan were included in this
study. All patients had received hemodialysis for more
than 3 months before this study. They had no evidence
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of active psychiatric disease, infection, uncontrolled con-
gestive heart failure (more severe than New York Heart
Association functional class II), or acute complications
from uremia at the time of study. Those who refused to
join the study were excluded. Other exclusion criteria
included cognitive impairment, history of alcohol or sub-
stance abuse, unstable monogamous relationships with
multiple male partners, and poorly controlled diabetes
mellitus.
Biochemical and hematologic parameters were ob-
tained by midweek predialysis blood samples within 1
month of this study. Other clinical variables, including
marital status, duration on hemodialysis, primary renal
disease, comorbid diseases, and medications in use, were
also documented.
Questionnaires
After written informed consent was obtained, each pa-
tient was asked to complete three questionnaires on her
own: (1) the Index of Female Sexual Function (IFSF) to
assess sexual function; (2) the Beck Depression Inventory
(BDI) (Chinese Version) to rate the severity of depres-
sive symptoms; and (3) the 36-item Short Form Health
Survey Questionnaire (SF-36, Taiwan Standard Version
1.0) to survey quality of life.
The self-administered questionnaire, IFSF, has been
used to assess sexual function in the normal popula-
tion [6]. Linguistic validation of this questionnaire was
conducted in Chinese. This process included two-way
translations of the questionnaire items and comprehen-
sive testing of the final item pool. The specific dimensions
and questions analyzed in the IFSF included quality of
sexual intercourse (questions 1 and 2; possible total score,
0 to 10), desire (questions 4 and 5; possible total score, 2
to 10), overall satisfaction with sexual function (questions
6 and 7; possible total score, 2 to 10), ability to achieve or-
gasm (question 8; possible total score, 1 to 5), the degree
of lubrication (question 2; possible total score, 0 to 5), and
the degree of clitoral sensation (question 9; possible total
score, 1 to 5). The responses were graded on a scale of 1
(almost never or never) to 5 (almost always or always). A
score of 0 indicated no attempt at intercourse. The highest
possible total score was 45 (range 5 to 45), and the lower
scores represented lower sexual function. For comparing
with normal Chinese female population, 62 healthy peri-
or postmenopausal female volunteers, aged from 40 to
60 years old, were recruited to participate in this sexual
function survey.
The BDI is a standard self-administered questionnaire
used to screen patients for depression [7] and had been
used in the assessment of depression in ESRD patients
[8, 9]. BDI scores of 14 to 19 represent a mild degree of
depression, 20 to 28 a moderate degree, and 29 to 60 a
severe degree of depression. The SF-36 is an instrument
commonly utilized to measure quality of life in the gen-
eral and uremic populations [10, 11]. It includes eight
scales: physical functioning, role physical, bodily pain,
general health, vitality, social functioning, role emotional,
and mental health. Low scores in the eight domains in-
dicate lower quality of life. These eight scales have been
compressed into two primary summary scales: the physi-
cal component scale and the mental component scale. Be-
cause there were no standard steps of transformation and
aggregation of scale scores in the Chinese population, we
did not transform the SF-36 scores to the summary scales.
This study was approved by the Ethical Committee
of Hospitals and monitored by the Institutional Review
Board.
Statistics
The patients’ characteristics were presented as mean
± SD. The Kolmogorov-Smirnov test and Shapiro-Wilk
test of normality were used for data distribution analy-
sis. The nonparametric Mann-Whitney U test was used to
test differences between patients and healthy volunteers.
Spearman’s rho correlation test was used in screening the
independent variables of sexual function scores. If P val-
ues were less than 0.10, the variables would be included in
further regression analysis. Step-wise multiple linear re-
gression analysis with both backward elimination and for-
ward selection was employed to evaluate any association
between sexual function scores as the outcome variable
and multiple independent variables. A two-tailed P value
<0.05 was considered statistically significant. For study-
ing the association between the scores of sexual function
and quality of life, step-wise multivariable linear regres-
sion were used for analysis. All calculations were per-
formed using a standard statistical package (SPSS 10.0
for Windows) (SSPS Inc., Chicago, IL, USA).
RESULTS
One hundred and forty-three patients completed the
IFSF questionnaires with a response rate of 24.7%.
Among the nonresponders, 113 (19.6%) patients refused
this survey, 291 (50.3%) patients did not complete this
survey because of no more sexual activity, and 31 (5.3%)
patients never had sexual experience before. That meant
that at least 322 (55.7%) patients had no sexual life dur-
ing our study period. Five responding patients were ex-
cluded because of incomplete survey results on quality
of life. A total of 138 female patients were enrolled for
further analysis. The mean age was 48.7 ± 11.2 (range
22 to 81) years old, much younger than non-responders
(60.2 ± 13.2 years old) (P < 0.001). They had been receiv-
ing hemodialysis 53.3 ± 41.8 months before the study.
Eighteen (13%) patients had diabetes mellitus and 28
(20.3%) patients had hypertension. No patient received
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Table 1. Demographic and clinical characteristics of study patients
Number (%) Mean ± SD
Patient demographics
Age years 48.7 ± 11.2
Dialysis duration months 53.3 ± 41.8
Married number (%) 127 (92.0)
Diabetes number (%) 18 (13.0)
Hypertension number (%) 28 (20.3)
Etiology of end-stage renal disease
Chronic glomerulonephritis (%) 64 (46.4)
Diabetic nephropathy (%) 16 (11.6)
Hypertensive nephropthy (%) 10 (7.2)
Lupus nephritis (%) 8 (5.8)
Polycystic kidney disease (%) 5 (3.6)
Undetermined (%) 35 (25.4)
Patients clinical characteristics
Albumin g/dL 4.1 ± 0.3
Hematocrit % 29.0 ± 4.2
Predialysis creatinine mg/dL 10.4 ± 1.6
Predialysis blood urea nitrogen mg/dL 73.7 ± 16.9
Serum uric acid mg/dL 7.4 ± 1.5
Total serum calcium mg/dL 9.5 ± 0.9
Serum phosphorus mg/dL 5.0 ± 1.3
Serum iron lg/dL 75.1 ± 33.2
Serum ferritin ng/mL 522.0 ± 439.0
Single-pool Kt/V 1.49 ± 0.24
Triglyceride mg/dL 177.8 ± 119.6
Total cholesterol mg/dL 203.2 ± 43.5
Intact parathyroid hormone pg/mL 201.64 ± 200.0
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Fig. 1. The distribution frequency of the total Index of Female Sexual
Function (IFSF) score. The mean IFSF score for all patients was 24.5 ±
9.3, and the median score was 27.
beta blocker treatment. Other clinical characteristics are
listed in Table 1.
Prevalence of sexual dysfunction
The mean IFSF score for all patients was 24.5 ± 9.3,
and the median score was 27 (Fig. 1). Forty-one (29.7%)
patients had scores at 20 or less, 55 (39.9%) between 21
and 30, and only 42 (30.4%) patients had scores greater
than 30. The score distribution for individual dimensions
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Fig. 2. The distribution frequency of the six domains of sexual function.
Table 2. The sexual function of patients and healthy volunteers
Healthy
Patients volunteers
(N = 138) (N = 62) P value
Age 48.7 ± 11.2 50.1 ± 6.0 0.334
Quality of sexual intercourse 8 (2, 10) 8 (6, 10) 0.057
Sexual desire 6 (3, 7) 4 (4, 5) 0.095
Intercourse satisfaction 7 (6, 8) 8 (7, 8) 0.003
Degree of lubrication 4 (1, 5) 4 (3, 5) 0.008
Ability to achieve orgasm 2 (1, 4) 3 (2, 4) <0.001
Degree of clitoral sensation 3 (2, 4) 4 (3, 4) <0.001
Total score 27 (15.5, 32) 29 (25, 32) 0.034
The scores were presented by median (25th, 75th percentile).
is summarized in Figure 2. The mean score of sexual desire
was 4.8 ± 2.1, and the median score was 6. The mean score
of lubrication was 2.9 ± 2.0, and the median score was
4. The score of clitoral sensation was 2.7 ± 1.1, and the
median score was 3. The mean score of orgasms was 2.6 ±
1.4, and the median score was 2. The mean score of quality
of sexual intercourse was 6.2 ± 3.8, and the median score
was 8. The mean score of overall satisfaction with sexual
function was 6.7 ± 1.9, and the median score was 7. The
comparison between patients and healthy volunteers is
summarized in Table 2. Except in the dimension of sexual
desire, all the scores of other dimensions and total scores
were lower in the patient group.
The clinical parameters associated with sexual
dysfunction
In bivariate analysis, advanced age was strongly as-
sociated with dysfunction in the total score and each
dimension (P < 0.001). Diabetes was associated with dys-
function in the dimensions of desire, orgasms, and cli-
toral sensation (P = 0.027, P = 0.005, and P = 0.002,
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Table 3. Multiple linear regression model of individual sexual
function dimensions
Variable b Coefficient P value
Quality of sexual intercourse
Triglyceride −0.428 <0.001
Beck Depression Inventory score −0.303 0.003
Sexual desire
Beck Depression Inventory score −0.341 0.001
Triglyceride −0.317 0.002
Age −0.211 0.047
Intercourse satisfaction
Age −0.341 0.003
Degree of lubrication
Triglyceride −0.374 0.001
Beck Depression Inventory score −0.327 0.002
Ability to achieve orgasm
Beck Depression Inventory score −0.345 0.001
Triglyceride −0.300 0.005
Degree of clitoral sensation
Triglyceride −0.363 0.001
Age −0.345 0.002
Total serum calcium 0.267 0.006
Beck Depression Inventory score −0.254 0.010
Total score
Triglyceride −0.370 < 0.001
Age −0.286 0.005
Beck Depression Inventory score −0.306 0.002
respectively). Hypertriglyceridemia was strongly associ-
ated with dysfunction in the dimensions of quality, de-
sire, clitoral lubrication, orgasms, and clitoral sensation
(P = 0.001, P < 0.001, P 0.005, P 0.013, and P < 0.001,
respectively). Furthermore, hypertriglyceridemia was as-
sociated lower total IFSF scores (P < 0.001). The history
of cardiovascular diseases was found to be associated with
an increase in the dysfunction of the dimensions of satis-
faction, orgasms, and clitoral sensation (P = 0.010, P =
0.037, and P = 0.021, respectively). The association of ad-
equacy of dialysis and sexual function was also analyzed.
However, by bivariate analysis, urea clearance (Kt/V) was
not found to be associated with dysfunction in any sexual
dimension. If dividing patients to two groups of inade-
quate dialysis (Kt/V < 1.2) (N = 10) and adequate dialy-
sis (Kt/V >1.2) (N= 128), the scores of these two groups
in each sexual dimension were similar (P > 0.10). The
serum albumin and time on dialysis were not associated
with sexual dysfunction, either. Higher hematocrit lev-
els were only associated with a higher score of orgasms
(P = 0.005). Higher depression scores on the BDI were
significantly associated with lower scores in each dimen-
sion and the total score (P < 0.001).
By multiple linear regression analysis, age, higher BDI
scores, and hypertriglyceridemia were found to be inde-
pendent factors of dysfunction in each sexual functional
dimension (Table 3). Although unadjusted analyses sug-
gested that hematocrit levels, history of cardiovascular
disease, and diabetes were significantly associated with
sexual dysfunction, none were associated with sexual dys-
Table 4. Association between female sexual function
and quality of life
Quality of
Sexual function dimension life dimension b Coefficient P value
Sexual desire PF 0.280 0.015
SF 0.251 0.018
Degree of lubrication PF 0.313 0.006
RP 0.289 0.012
Degree of clitoral sensation — — —
Ability to achieve orgasm MH 0.328 0.004
PF 0.304 0.007
Quality of sexual intercourse PF 0.317 0.009
Inter course satisfaction GH 0.355 0.001
Total score PF 0.300 0.007
MH 0.234 0.018
Adjusted by patients’ age, time on dialysis, diabetes, cardiovascular disease,
hematocrit levels, parathyroid hormone levels, predialytic blood urea nitrogen
and serum creatinine, triglyceride, total cholesterol, marital status, and Beck
Depression Inventory score. Abbreviations are: PF, physical functioning; SF,
social functioning; RP, role physical, MH, mental health, GH, general health.
function after adjustment for age, psychologic depression
scores, and serum triglyceride levels.
Association of sexual dysfunction and decreased quality
of life
Multiple linear regression analysis was used to exam-
ine the associations between various measures of quality
of life, sexual dysfunction, psychologic depression, and
other clinical variables (Table 4). After this adjustment,
we found that patients with higher total scores had signif-
icantly higher scores in the dimensions of mental health
and physical functioning. Higher sexual desire scores pre-
dicted higher scores in physical and social functioning
(P = 0.015 and P = 0.018, respectively). The higher scores
in the dimension of degree of lubrication were associated
with higher scores in the dimensions of physical function-
ing and role limitation (P = 0.006 and P = 0.012, respec-
tively). Patients with higher intercourse satisfaction had
significantly higher general health scores (P = 0.001).
DISCUSSION
Sexual evaluation must include a comprehensive
patient history, physical examination, and psychologic
evaluation. Physiologic evaluation of sexual response
(vaginal photoplethysmography or duplex ultrasonogra-
phy) has been used in some instances but is not uniformly
available. Some authors have advocated the use of bio-
chemical and hormonal evaluation, but such reports have
not been able to relate these measures to sexual dysfunc-
tion [12]. Multidimensional self-report questionnaires are
still the most widely used instruments in evaluating fe-
male sexual dysfunction. In this survey, we have produced
five major findings.
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First, in our patients, the mean IFSF score was only
24.5 ± 9.3 (median 27), comparable to the score of “post-
menopausal women with sexual dysfunction” in the study
of Kaplan et al [6]. This score was probably lower than
that of a report of diabetic women (29.3 ± 6.4) [13]. In
contrast to the peri- or postmenopausal Chinese women,
our patients had still lower scores in most sexual dimen-
sions. These observations imply that the prevalence of
sexual dysfunction in our hemodialysis subjects is high.
Although the total scores were low, the scores of inter-
course satisfaction in our patient group were higher than
those in previous studies [6, 13]. Such a discrepancy may
be due to the higher degree of conservatism in sexual
attitudes of Chinese people.
Second, regardless of the total score or scores for
individual dimensions, increasing age and hypertriglyc-
eridemia were the major physical factors associated with
sexual dysfunction. The association of increasing age and
sexual dysfunction has been previously demonstrated in
nonuremic subjects [14]. In elderly subjects, vascular in-
sufficiency, comorbid diseases, decreased organ function,
and self-body image change have been claimed as the
leading factors in sexual dysfunction. The vasculogenic
factor of female sexual dysfunction should receive more
attention. A recently named clitoral and vaginal vascular
insufficiency syndrome was introduced by Goldstein and
Berman [15]. This disorder is directly related to dimin-
ished genital blood flow secondary to atherosclerosis of
iliohypogastric/pudendal arterial bed. Diminished pelvic
blood flow leads to vaginal wall and clitoral smooth mus-
cle fibrosis [16], which may impair with normal relaxation
and dilation responses to sexual stimulation and result in
symptoms of vaginal dryness and dyspareunia. Uremic
patients with increased serum triglycerides have usually
had more advanced atherosclerosis [17]. This implicates
vascular insufficiency as the major cause of sexual dys-
function in our hypertriglycemic patients.
Third, our results did not disclose the adequacy of dial-
ysis to be associated with sexual dysfunction. In our study,
the Kt/V was less than 1.2 in only ten patients and serum
albumin was less than 3.5 mg/dL in only five patients. The
numbers of inadequate dialysis patients was so limited, so
we could not explore the exact sexual disorders in them.
According to these results, we can conclude only that
higher Kt/V than 1.2 does not prevent sexual dysfunction
in female hemodialysis patients.
Fourth, our study demonstrated that the degree of sex-
ual dysfunction in female hemodialysis patients could be
directly correlated with the degree of depressive symp-
toms. Previous studies have also demonstrated that emo-
tional issues significantly affect sexual behaviors in nor-
mal populations [18]. Depressive disorder is a common
psychologic disturbance and is associated with increased
mortality in dialysis patients [8]. Our results suggest that,
in evaluating sexual dysfunction of hemodialysis patients,
exploration and management of depressive disorders are
absolutely necessary.
Fifth, we demonstrated that, in female hemodialysis pa-
tients, sexual dysfunction is associated with lower physical
functioning and mental health. Those patients with higher
sexual desire had better social functioning. The sexual
dysfunction and quality of life often interfered with each
other. Any physical or psychologic disorders that could
affect one’s quality of life also affected sexual desire and
function. On the other hand, because the inability to have
normal sexual life can erode an individual’s sense of self-
esteem and lead to emotional and marital tension, qual-
ity of life is diminished in patients [19]. Such findings are
comparable with that of male hemodialysis patients [20].
As the first large-scale study to analyze sexual dys-
function in female hemodialysis patients, there are, in-
evitably, some limitations of the study. First, the response
rate in our survey was low (24.7%). Sex research is gen-
erally characterized by a bias due to volunteer partici-
pation [21]. The women who refused participation had a
higher degree of conservatism in sexual attitudes. There
were 322 (55.7%) patients who had no sexual life during
our study. Because of sexual life is greatly influenced by
physical capacity, psychologic disorders, widowhood, and
even the interrelationship between couples. It is difficult
to clarify the exact cause. It is impossible to know how
much difference existed between responders and nonre-
sponders. Second, the number of controlled healthy vol-
unteers in our study is limited. It has been demonstrated
that women of different racial groups have different pat-
terns of sexual dysfunction [22]. Unfortunately, we are
not aware of any study on a large scale regarding Chinese
female sexual function. Third, only 18 (13.0%) of diabetic
patients were included in our study, and the result re-
vealed that diabetes alone was not an independent factor
in each sexual dimension. The study of sexual dysfunc-
tion in diabetic women is scarce. Further research about
the impact of diabetes on female sexual dysfunction is
necessary. Fourth, we disclosed the association of serum
triglyceride levels and sexual dysfunction. Further phys-
iologic evaluations, such as vaginal photoplethysmogra-
phy or duplex ultrasonography, are sill needed to support
such a conclusion.
CONCLUSION
Sexual dysfunction is highly prevalent in the female
hemodialysis population. It is strongly associated with in-
creasing age, dyslipidemia, and depression. Subjects with
sexual dysfunction have poorer quality of life. The di-
agnosis and treatment of sexual dysfunction should be
included in clinical assessment. Future research should
include evaluation of the effectiveness of treatment of
sexual dysfunction and assessment of changes in quality
of life after therapy.
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